Office of Technology Development: Technologies Available for Licensing

Memorial Sloan-Kettering is developing an extensive assortment of technologies with applications for oncology and many other areas of healthcare and science. We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.

Explore our list of technologies available for licensing below, and filter by technology categories.

Some of our newest technologies may not appear in this list. To learn about recent developments, contact any member of our staff about your particular interests.

Showing 1 - 20 of 76 technologies
Title Categories
2-[18F]-Labeled Compounds and PET Imaging of Tumors for Enhanced Diagnostic and Therapeutic Monitoring Purposes
[SK1365]
  • DiagnosticsImaging
  • IndicationsCancer
A Novel and Efficient Method for Fat-Free Nuclear Magnetic Imaging
[SK1302]
  • Diagnostics
Acid Sphingomyelinase: A New Drug Target to Regulate Apoptosis
[SK 737]
  • Research Tools
An Effective Cancer Vaccine Combination
[SK1230]
  • Vaccines
An Improved Apparatus for One-Lung Isolation
[SK1063]
  • Devices
Analogs of Actinonin as Antitumor Compounds
[SK 934]
  • Therapeutics
Apparatus that Facilitates Cell Growth and Screening under Variable Hydrostatic Pressures
[SK1017]
  • Devices
  • Research Tools
Apparatus that Improves Optics in Multi-Photon Laser Scanning Microscopes
[SK 951]
  • Devices
Caki-1: Human Renal Cancer Cell Line
[SK1980-534 ]
  • IndicationsCancerUrinary System
  • Research ToolsCell Lines
CAMA-1: Human Breast Cancer Cell Line
[SK 926]
  • IndicationsCancerBreast
  • Research ToolsCell Lines
Cancer Diagnosis and Prognosis by Determining Levels of MDM2 and p53 and Antibodies Against MDM2
[SK 596]
  • Diagnostics
Cancer Marker Discovery and Validation
[SK1181]
  • Diagnostics
Cathepsin Inhibitor Combined Therapy Provides Enhanced Treatment of Solid Tumors
[SK1326]
  • Therapeutics
Chimeric Antigen Receptors for Adoptive Cell Therapy
[SK1036/SK1276]
  • IndicationsCancer
  • TherapeuticsCell/Gene therapies
Combinations of PKC Inhibitors and Therapeutic Agents for Treatment of Cancer
[SK 684]
  • Therapeutics
Cryoarray System and Methods for Creating a Frozen Tissue Array
[SK 932]
  • Research Tools
Detailed Description
[SK1084]
  • Diagnostics
Device to Reduce Pain from Needle Injections and Other Medical Procedures
[SK1497]
  • DevicesHospital Care
Directed Differentiation of ES Cells to Neurospecific Lineages for Therapeutic and Research Use
[SK2011-004]
  • Research Tools
  • Therapeutics
Flourine-18 Dasatinib Derivative For Pet Imaging Of Tumors
[SK1319]
  • Diagnostics
  • IndicationsCancer